Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-23 4:25 pm Purchase | 13D | TSCAN THERAPEUTICS INC TCRX | BAKER BROS. ADVISORS LP | 2,828,938 6.1% | 35,000 (+1.25%) | View |
| 2024-04-18 07:29 am Purchase | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | BAKER BROS. ADVISORS LP | 7,689,243 19.9% | 2,865,645 (+59.41%) | View |
| 2024-04-01 08:57 am Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | BAKER BROS. ADVISORS LP | 5,997,706 9.8% | 1,778 (+0.03%) | View |
| 2024-03-28 7:13 pm Purchase | 13D | IGM BIOSCIENCES INC IGMS | BAKER BROS. ADVISORS LP | 4,145,706 12.4% | 401,037 (+10.71%) | View |
| 2024-03-25 4:28 pm Purchase | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 2,070,544 9.99% | 82,842 (+4.17%) | View |
| 2024-03-05 4:24 pm Purchase | 13D | VTV THERAPEUTICS INC VTVT | BAKER BROS. ADVISORS LP | 122,664 4.99% | 122,664 (New Position) | View |
| 2024-02-14 4:21 pm Purchase | 13G | 2SEVENTY BIO INC TSVT | BAKER BROS. ADVISORS LP | 2,527,672 4.99% | 464,928 (+22.54%) | View |
| 2024-02-14 4:21 pm Purchase | 13G | ABCELLERA BIOLOGICS INC. ABCL | BAKER BROS. ADVISORS LP | 22,909,753 7.9% | 22,909,753 (New Position) | View |
| 2024-02-14 4:21 pm Sale | 13G | ACHILLES THERAPEUTICS PLC ACHL | BAKER BROS. ADVISORS LP | 3,311,567 8.1% | -896,166 (-21.30%) | View |
| 2024-02-14 4:21 pm Sale | 13G | INOZYME PHARMA INC INZY | BAKER BROS. ADVISORS LP | 0 0% | -2,168,000 (Position Closed) | View |
| 2024-02-14 4:21 pm Sale | 13G | ZYMEWORKS INC ZYME | BAKER BROS. ADVISORS LP | 27,000 0.04% | -3,787,196 (-99.29%) | View |
| 2024-02-14 4:21 pm Sale | 13G | MIRATI THERAPEUTICS INC MRTX | BAKER BROS. ADVISORS LP | 0 0% | -1,995,200 (Position Closed) | View |
| 2024-02-14 4:21 pm Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | BAKER BROS. ADVISORS LP | 65,815,692 4.8% | 6,830,430 (+11.58%) | View |
| 2024-02-14 4:21 pm Sale | 13G | AEROVATE THERAPEUTICS INC AVTE | BAKER BROS. ADVISORS LP | 1,680,517 6.1% | -296,351 (-14.99%) | View |
| 2024-02-14 4:21 pm Unchanged | 13G | SPYRE THERAPEUTICS, INC SYRE | BAKER BROS. ADVISORS LP | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 4:21 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | BAKER BROS. ADVISORS LP | 3,664,013 4.99% | 1,587,613 (+76.46%) | View |
| 2024-02-14 4:21 pm Sale | 13G | VERSARTIS INC ARAV | BAKER BROS. ADVISORS LP | 3,863,568 4.99% | -722,836 (-15.76%) | View |
| 2024-02-14 4:21 pm Purchase | 13G | CABALETTA BIO INC CABA | BAKER BROS. ADVISORS LP | 1,457,626 3.4% | 113,626 (+8.45%) | View |
| 2024-02-14 4:21 pm Unchanged | 13G | AKERO THERAPEUTICS INC AKRO | BAKER BROS. ADVISORS LP | 2,368,378 4.3% | 0 (Unchanged) | View |
| 2024-02-14 4:21 pm Sale | 13G | HERON THERAPEUTICS INC HRTX | BAKER BROS. ADVISORS LP | 7,881,933 4.99% | -249,745 (-3.07%) | View |